Cargando…

Current Strategies to Enhance Anti-Tumour Immunity

The interaction of the immune system with cancer is complex, but new approaches are resulting in exciting therapeutic benefits. In order to enhance the immune response to cancer, immune therapies seek to either induce high avidity immune responses to tumour specific antigens or to convert the tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, Katherine W., Durrant, Lindy G., Brentville, Victoria A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027499/ https://www.ncbi.nlm.nih.gov/pubmed/29570634 http://dx.doi.org/10.3390/biomedicines6020037

Ejemplares similares

Citrullinated Epitopes Identified on Tumour MHC Class II by Peptide Elution Stimulate Both Regulatory and Th1 Responses and Require Careful Selection for Optimal Anti-Tumour Responses
por: Symonds, Peter, et al.
Publicado: (2021)

Citrullinated α-enolase is an effective target for anti-cancer immunity
por: Cook, Katherine, et al.
Publicado: (2017)

A Novel HAGE/WT1-ImmunoBody(®) Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone
por: Almshayakhchi, Rukaia, et al.
Publicado: (2021)

SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors
por: Xue, Wei, et al.
Publicado: (2016)

Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity
por: Cook, Katherine, et al.
Publicado: (2022)

T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy
por: Brentville, Victoria A, et al.
Publicado: (2019)

High Avidity Cytotoxic T Lymphocytes Can Be Selected into the Memory Pool but They Are Exquisitely Sensitive to Functional Impairment
por: Brentville, Victoria A., et al.
Publicado: (2012)

Cancer Vaccines, Adjuvants, and Delivery Systems
por: Paston, Samantha J., et al.
Publicado: (2021)

Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity
por: Shah, Sabaria, et al.
Publicado: (2023)

SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade
por: Xue, Wei, et al.
Publicado: (2016)

PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy
por: Choudhury, Ruhul H, et al.
Publicado: (2022)

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses
por: Brentville, Victoria A, et al.
Publicado: (2020)

Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy
por: Cook, Katherine W, et al.
Publicado: (2021)

Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy
por: Brentville, Victoria Anne, et al.
Publicado: (2022)

Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity
por: Dongye, Zhangchi, et al.
Publicado: (2022)

MicroRNAs Involved in Anti-Tumour Immunity
por: Yu, Hong W. H., et al.
Publicado: (2013)

Macrophage-Mediated Subversion of Anti-Tumour Immunity
por: Quaranta, Valeria, et al.
Publicado: (2019)

Gastrin: growth enhancing effects on human gastric and colonic tumour cells.
por: Watson, S., et al.
Publicado: (1989)

Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
por: Anfray, Clément, et al.
Publicado: (2019)

Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
por: Grépin, Renaud, et al.
Publicado: (2010)

Modulation of Anti-Tumour Immune Responses by Probiotic Bacteria
por: Aindelis, Georgios, et al.
Publicado: (2020)

Ionic Regulation of T-Cell Function and Anti-Tumour Immunity
por: Ginefra, Pierpaolo, et al.
Publicado: (2021)

Current endoscopic diagnosis treatment strategy for superficial nonampullary duodenal tumours
por: Li, Aichun, et al.
Publicado: (2022)

Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
por: Peña-Romero, Alicia Cristina, et al.
Publicado: (2022)

Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
por: Durrant, L. G., et al.
Publicado: (1989)

Photodynamic Therapy-Induced Anti-Tumor Immunity: Influence Factors and Synergistic Enhancement Strategies
por: Chou, Wenxin, et al.
Publicado: (2023)

Polyamine Depletion Strategies in Cancer: Remodeling the Tumor Immune Microenvironment to Enhance Anti-Tumor Responses
por: Chin, Alexander, et al.
Publicado: (2022)

Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses
por: Hossain, Md Kamal, et al.
Publicado: (2019)

Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity
por: Persano, Stefano, et al.
Publicado: (2021)

Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

A tale of two tumours: Comparison of the immune escape strategies of contagious cancers()
por: Siddle, Hannah V., et al.
Publicado: (2013)

Current strategies in engaging oncolytic viruses with antitumor immunity
por: Boagni, Drew Ashton, et al.
Publicado: (2021)

Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain
por: Bajracharya, Rinie, et al.
Publicado: (2021)

The Role of Non-essential Amino Acids in T Cell Function and Anti-tumour Immunity
por: Hope, Helen Carrasco, et al.
Publicado: (2021)

Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses
por: Campbell, Katrin, et al.
Publicado: (2021)

Mutations in the notch signalling pathway are associated with enhanced anti‐tumour immunity in colorectal cancer
por: Wang, Fei, et al.
Publicado: (2020)

Studies on the effector cell of anti-tumour immunity in a chemically induced mouse tumour system.
por: Whitney, R. B., et al.
Publicado: (1975)

Cancer cell associated glycans as targets for immunotherapy
por: Vankemmelbeke, Mireille, et al.
Publicado: (2015)

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial
por: Patel, Poulam M., et al.
Publicado: (2018)

Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours
por: Cheng, Ya Qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q5bee81ta85usq8kusam74dcl3